RVMDW
Revolution Medicines, Inc. Warrant
NASDAQ · Healthcare · Biotechnology · US
$11.89
−0.79%Leverage
- Debt / equity
- 0.25x
- Net debt / equity
- -0.07x
- Debt / assets
- 0.15x
- Debt / EBITDA
- -0.38x
- Net debt / EBITDA
- 0.10x
Liquidity & coverage
- Current ratio
- 11.38x
- Quick ratio
- 11.38x
- Cash ratio
- 11.12x
- Interest coverage
- -27.42x
- EBITDA / interest
- -28.57x
- Working capital
- $3.7B
Cash & dividend
- FCF / debt
- -2.47x
- Cash flow / debt
- -2.46x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026